Antonio Jiménez Abraham specialises in renewable energies as well as financing and project finance. He serves as secretary of the executive board of Asociación Balear de Energías Renovables, is a regular speaker on renewable energy matters and frequently participates in conferences and other events relating to this topic.
He has gained extensive experience in biotech as outside counsel of various biotech companies in which Caixa Capital Risc holds an interest. From September 2016 to July 2022, Antonio Jiménez was on special, voluntary leave of absence in order to serve as general counsel and vice president of operations of the biotech company Sanifit Therapeutics S.A. until its acquisition by the Swiss pharmaceutical company Vifor Pharma.
Antonio Jiménez studied law at Universidad de las Islas Baleares and Paris Lodron Universität Salzburg. He also has a postgraduate degree in urban planning and zoning law from Universidad de las Islas Baleares.
He speaks Spanish, English, German and Catalan.